Published in Clin Chem on February 06, 2009
Liquid biopsies: genotyping circulating tumor DNA. J Clin Oncol (2014) 4.76
COLD-PCR-enhanced high-resolution melting enables rapid and selective identification of low-level unknown mutations. Clin Chem (2009) 2.17
Two-round coamplification at lower denaturation temperature-PCR (COLD-PCR)-based sanger sequencing identifies a novel spectrum of low-level mutations in lung adenocarcinoma. Hum Mutat (2009) 1.97
Ice-COLD-PCR enables rapid amplification and robust enrichment for low-abundance unknown DNA mutations. Nucleic Acids Res (2010) 1.38
Predicting response to epigenetic therapy. J Clin Invest (2014) 1.16
Mutant enrichment with 3'-modified oligonucleotides a practical PCR method for detecting trace mutant DNAs. J Mol Diagn (2011) 1.12
NRAS mutations with low allele burden have independent prognostic significance for patients with lower risk myelodysplastic syndromes. Leukemia (2013) 1.01
COLD-PCR: improving the sensitivity of molecular diagnostics assays. Expert Rev Mol Diagn (2011) 0.97
Competitive amplification of differentially melting amplicons (CADMA) improves KRAS hotspot mutation testing in colorectal cancer. BMC Cancer (2012) 0.95
EGFR tyrosine kinase mutation testing in the treatment of non-small-cell lung cancer. Curr Oncol (2012) 0.93
Multiplex amplification coupled with COLD-PCR and high resolution melting enables identification of low-abundance mutations in cancer samples with low DNA content. J Mol Diagn (2011) 0.90
Conversion strategy using an expanded genetic alphabet to assay nucleic acids. Anal Chem (2013) 0.90
DISSECT Method Using PNA-LNA Clamp Improves Detection of EGFR T790m Mutation. PLoS One (2013) 0.87
Temperature-tolerant COLD-PCR reduces temperature stringency and enables robust mutation enrichment. Clin Chem (2012) 0.87
Identification of a rare 3 bp BRAF gene deletion in a thyroid nodule by mutant enrichment with 3'-modified oligonucleotides polymerase chain reaction. Ann Lab Med (2012) 0.85
Differential strand separation at critical temperature: a minimally disruptive enrichment method for low-abundance unknown DNA mutations. Nucleic Acids Res (2012) 0.84
RAS testing in metastatic colorectal cancer: advances in Europe. Virchows Arch (2015) 0.83
Enhanced ratio of signals enables digital mutation scanning for rare allele detection. J Mol Diagn (2015) 0.82
Peptide nucleic acid clamp polymerase chain reaction reveals a deletion mutation of the BRAF gene in papillary thyroid carcinoma: A case report. Exp Ther Med (2013) 0.79
Liquid biopsy for detection of actionable oncogenic mutations in human cancers and electric field induced release and measurement liquid biopsy (eLB). Analyst (2016) 0.78
One-Step Ligation on RNA Amplification for the Detection of Point Mutations. J Mol Diagn (2015) 0.77
Predicting Radiotherapy Responses and Treatment Outcomes Through Analysis of Circulating Tumor DNA. Semin Radiat Oncol (2015) 0.77
Kinetic hairpin oligonucleotide blockers for selective amplification of rare mutations. Sci Rep (2014) 0.77
Elimination of unaltered DNA in mixed clinical samples via nuclease-assisted minor-allele enrichment. Nucleic Acids Res (2016) 0.77
Application of coamplification at lower denaturation temperature-PCR sequencing for early detection of antiviral drug resistance mutations of hepatitis B virus. J Clin Microbiol (2014) 0.77
Superior Multiplexing Capacity of PlexPrimers Enables Sensitive and Specific Detection of SNPs and Clustered Mutations in qPCR. PLoS One (2017) 0.75
Clinical impact of mutation fraction in epidermal growth factor receptor mutation positive NSCLC patients. Br J Cancer (2016) 0.75
Mrassf1a-pap, a novel methylation-based assay for the detection of cell-free fetal DNA in maternal plasma. PLoS One (2013) 0.75
Evaluation of the Anyplex BRAF V600E real-time detection assay using dual-priming oligonucleotide technology in fine-needle aspirates of thyroid nodules. Ann Lab Med (2015) 0.75
Single-tube, highly parallel mutation enrichment in cancer gene panels by use of temperature-tolerant COLD-PCR. Clin Chem (2014) 0.75
Methylation-sensitive enrichment of minor DNA alleles using a double-strand DNA-specific nuclease. Nucleic Acids Res (2016) 0.75
High-resolution melting (HRM) re-analysis of a polyposis patients cohort reveals previously undetected heterozygous and mosaic APC gene mutations. Fam Cancer (2015) 0.75
Enrichment of mutations in multiple DNA sequences using COLD-PCR in emulsion. PLoS One (2012) 0.75
Single-Tubed Wild-Type Blocking Quantitative PCR Detection Assay for the Sensitive Detection of Codon 12 and 13 KRAS Mutations. PLoS One (2015) 0.75
Extendable blocking probe in reverse transcription for analysis of RNA variants with superior selectivity. Nucleic Acids Res (2014) 0.75
Modified Proofreading PCR for Detection of Point Mutations, Insertions and Deletions Using a ddNTP-Blocked Primer. PLoS One (2015) 0.75
Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms. Proc Natl Acad Sci U S A (1989) 18.26
Analysis of any point mutation in DNA. The amplification refractory mutation system (ARMS). Nucleic Acids Res (1989) 15.35
Sequence-selective recognition of DNA by strand displacement with a thymine-substituted polyamide. Science (1991) 12.17
Digital PCR. Proc Natl Acad Sci U S A (1999) 10.54
Sensitive mutation detection in heterogeneous cancer specimens by massively parallel picoliter reactor sequencing. Nat Med (2006) 6.96
Allele-specific enzymatic amplification of beta-globin genomic DNA for diagnosis of sickle cell anemia. Proc Natl Acad Sci U S A (1989) 5.30
A pre-Columbian Y chromosome-specific transition and its implications for human evolutionary history. Proc Natl Acad Sci U S A (1996) 4.52
Resolution of a missense mutant in human genomic DNA by denaturing gradient gel electrophoresis and direct sequencing using in vitro DNA amplification: HPRT Munich. Am J Hum Genet (1988) 3.50
Mismatch amplification mutation assay (MAMA): application to the c-H-ras gene. PCR Methods Appl (1992) 3.42
Replacing PCR with COLD-PCR enriches variant DNA sequences and redefines the sensitivity of genetic testing. Nat Med (2008) 3.08
Rapid, nonradioactive detection of mutations in the human genome by allele-specific amplification. J Lab Clin Med (1989) 2.22
Detection of single DNA base differences by competitive oligonucleotide priming. Nucleic Acids Res (1989) 2.14
Detection of minority point mutations by modified PCR technique: a new approach for a sensitive diagnosis of tumor-progression markers. Nucleic Acids Res (1989) 2.04
Quantification of random genomic mutations. Nat Methods (2005) 1.88
Antiprimer quenching-based real-time PCR and its application to the analysis of clinical cancer samples. Clin Chem (2006) 1.66
Rapid and sensitive nonradioactive detection of mutant K-ras genes via 'enriched' PCR amplification. Oncogene (1991) 1.59
A novel method for detecting point mutations or polymorphisms and its application to population screening for carriers of phenylketonuria. Mayo Clin Proc (1989) 1.54
Mutation detection using immobilized mismatch binding protein (MutS). Nucleic Acids Res (1995) 1.49
Restriction endonuclease-mediated selective polymerase chain reaction: a novel assay for the detection of K-ras mutations in clinical samples. Am J Pathol (1998) 1.37
Detection of K-ras mutation in sputum by mutant-allele-specific amplification (MASA). Hum Mutat (1993) 1.35
Genotypic selection methods for the direct analysis of point mutations. Mutat Res (1997) 1.30
FLAG assay as a novel method for real-time signal generation during PCR: application to detection and genotyping of KRAS codon 12 mutations. Nucleic Acids Res (2007) 1.21
Detection of non-homology-containing heteroduplex molecules. Nucleic Acids Res (1983) 1.20
Detection of Ki-ras mutations in tissue and plasma samples of patients with pancreatic cancer using PNA-mediated PCR clamping and hybridisation probes. Br J Cancer (2005) 1.18
Specific detection of bacillus anthracis using a TaqMan mismatch amplification mutation assay. Biotechniques (2005) 1.15
Wild-type blocking polymerase chain reaction for detection of single nucleotide minority mutations from clinical specimens. Oncogene (2005) 1.13
Pyrophosphorolysis-activated polymerization (PAP): application to allele-specific amplification. Biotechniques (2000) 1.09
Restriction site mutation analysis, a proposed methodology for the detection and study of DNA base changes following mutagen exposure. Mutagenesis (1990) 1.02
s-RT-MELT for rapid mutation scanning using enzymatic selection and real time DNA-melting: new potential for multiplex genetic analysis. Nucleic Acids Res (2007) 0.97
High sensitivity EndoV mutation scanning through real-time ligase proofreading. Nucleic Acids Res (2004) 0.94
Simultaneous detection of multiple single-base alleles at a polymorphic site. Biotechniques (1991) 0.93
A sensitive scanning technology for low frequency nuclear point mutations in human genomic DNA. Nucleic Acids Res (2000) 0.91
Combining allele-specific fluorescent probes and restriction assay in real-time PCR to achieve SNP scoring beyond allele ratios of 1:1000. Biotechniques (2008) 0.91
Detection of ultrarare somatic mutation in the human TP53 gene by bidirectional pyrophosphorolysis-activated polymerization allele-specific amplification. Hum Mutat (2007) 0.90
Selective amplification of rare mutations using locked nucleic acid oligonucleotides that competitively inhibit primer binding to wild-type DNA. J Invest Dermatol (2007) 0.89
Mutation analysis using the restriction site mutation (RSM) assay. Mutat Res (1998) 0.89
Characterizing mutations in samples with low-level mosaicism by collection and analysis of DHPLC fractionated heteroduplexes. Hum Mutat (2003) 0.87
An amplification and ligation-based method to scan for unknown mutations in DNA. Hum Mutat (2002) 0.86
Enrichment methods for mutation detection. Ann N Y Acad Sci (2000) 0.85
Ligation of a primer at a mutation: a method to detect low level mutations in DNA. Mutagenesis (2002) 0.83
Inverse PCR-based RFLP scanning identifies low-level mutation signatures in colon cells and tumors. Cancer Res (2004) 0.81
Precision and performance characteristics of bisulfite conversion and real-time PCR (MethyLight) for quantitative DNA methylation analysis. J Mol Diagn (2006) 4.68
Replacing PCR with COLD-PCR enriches variant DNA sequences and redefines the sensitivity of genetic testing. Nat Med (2008) 3.08
Multicenter randomized controlled trial of percutaneous cryoablation versus radiofrequency ablation in hepatocellular carcinoma. Hepatology (2015) 2.81
The long rather than the short allele of 5-HTTLPR predisposes Han Chinese to anxiety and reduced connectivity between prefrontal cortex and amygdala. Neurosci Bull (2013) 2.78
KrasG12D-induced IKK2/β/NF-κB activation by IL-1α and p62 feedforward loops is required for development of pancreatic ductal adenocarcinoma. Cancer Cell (2012) 2.55
Complicated acute type B dissection: is surgery still the best option?: a report from the International Registry of Acute Aortic Dissection. JACC Cardiovasc Interv (2008) 2.47
Pax6 is a human neuroectoderm cell fate determinant. Cell Stem Cell (2010) 2.46
KRAS mutations and resistance to EGFR-TKIs treatment in patients with non-small cell lung cancer: a meta-analysis of 22 studies. Lung Cancer (2009) 2.27
COLD-PCR-enhanced high-resolution melting enables rapid and selective identification of low-level unknown mutations. Clin Chem (2009) 2.17
Glucocorticoids promote hepatic cholestasis in mice by inhibiting the transcriptional activity of the farnesoid X receptor. Gastroenterology (2012) 2.05
Molecular characterization of meiotic recombination across the 140-kb multigenic a1-sh2 interval of maize. Proc Natl Acad Sci U S A (2002) 1.98
Two-round coamplification at lower denaturation temperature-PCR (COLD-PCR)-based sanger sequencing identifies a novel spectrum of low-level mutations in lung adenocarcinoma. Hum Mutat (2009) 1.97
On evaluating molecular-docking methods for pose prediction and enrichment factors. J Chem Inf Model (2006) 1.90
Impact of duty hours restrictions on quality of care and clinical outcomes. Am J Med (2007) 1.81
Cediranib plus FOLFOX/CAPOX versus placebo plus FOLFOX/CAPOX in patients with previously untreated metastatic colorectal cancer: a randomized, double-blind, phase III study (HORIZON II). J Clin Oncol (2012) 1.73
Antiprimer quenching-based real-time PCR and its application to the analysis of clinical cancer samples. Clin Chem (2006) 1.66
Polymorphisms in the XPG gene and risk of gastric cancer in Chinese populations. Hum Genet (2012) 1.64
YN968D1 is a novel and selective inhibitor of vascular endothelial growth factor receptor-2 tyrosine kinase with potent activity in vitro and in vivo. Cancer Sci (2011) 1.53
Heterodimerization and cross-desensitization between the mu-opioid receptor and the chemokine CCR5 receptor. Eur J Pharmacol (2004) 1.45
Observation of microsphere movement driven by optical pulse. Opt Lett (2011) 1.42
Bevacizumab plus capecitabine and cisplatin in Chinese patients with inoperable locally advanced or metastatic gastric or gastroesophageal junction cancer: randomized, double-blind, phase III study (AVATAR study). Gastric Cancer (2014) 1.41
Role of age in acute type A aortic dissection outcome: report from the International Registry of Acute Aortic Dissection (IRAD). J Thorac Cardiovasc Surg (2010) 1.41
Localized dose enhancement to tumor blood vessel endothelial cells via megavoltage X-rays and targeted gold nanoparticles: new potential for external beam radiotherapy. Int J Radiat Oncol Biol Phys (2010) 1.38
Ice-COLD-PCR enables rapid amplification and robust enrichment for low-abundance unknown DNA mutations. Nucleic Acids Res (2010) 1.38
Microemulsion-based hydrogel formulation of ibuprofen for topical delivery. Int J Pharm (2006) 1.37
Do we really need closed-suction drainage in total hip arthroplasty? A meta-analysis. Int Orthop (2013) 1.35
Retrospective survey of 452 patients with inflammatory bowel disease in Wuhan city, central China. Inflamm Bowel Dis (2006) 1.32
Genetic variations of mTORC1 genes and risk of gastric cancer in an Eastern Chinese population. Mol Carcinog (2013) 1.32
Large sample size, wide variant spectrum, and advanced machine-learning technique boost risk prediction for inflammatory bowel disease. Am J Hum Genet (2013) 1.31
DNA amplification method tolerant to sample degradation. Genome Res (2004) 1.28
First prospective, population-based inflammatory bowel disease incidence study in mainland of China: the emergence of "western" disease. Inflamm Bowel Dis (2013) 1.25
COLD-PCR: a new platform for highly improved mutation detection in cancer and genetic testing. Biochem Soc Trans (2009) 1.25
Coamplification at lower denaturation temperature-PCR increases mutation-detection selectivity of TaqMan-based real-time PCR. Clin Chem (2009) 1.24
Deregulation of cdk5, hyperphosphorylation, and cytoskeletal pathology in the Niemann-Pick type C murine model. J Neurosci (2002) 1.24
Simultaneously typing nine serotypes of enteroviruses associated with hand, foot, and mouth disease by a GeXP analyzer-based multiplex reverse transcription-PCR assay. J Clin Microbiol (2011) 1.23
Targeted radiotherapy with gold nanoparticles: current status and future perspectives. Nanomedicine (Lond) (2014) 1.22
Multicenter phase II study of apatinib, a novel VEGFR inhibitor in heavily pretreated patients with metastatic triple-negative breast cancer. Int J Cancer (2014) 1.22
Oligodendrocyte-specific activation of PERK signaling protects mice against experimental autoimmune encephalomyelitis. J Neurosci (2013) 1.22
Bystander effect produced by radiolabeled tumor cells in vivo. Proc Natl Acad Sci U S A (2002) 1.21
FLAG assay as a novel method for real-time signal generation during PCR: application to detection and genotyping of KRAS codon 12 mutations. Nucleic Acids Res (2007) 1.21
Do we really need tranexamic acid in total hip arthroplasty? A meta-analysis of nineteen randomized controlled trials. Arch Orthop Trauma Surg (2013) 1.20
Oxidative lipidomics of hyperoxic acute lung injury: mass spectrometric characterization of cardiolipin and phosphatidylserine peroxidation. Am J Physiol Lung Cell Mol Physiol (2010) 1.19
Balanced-PCR amplification allows unbiased identification of genomic copy changes in minute cell and tissue samples. Nucleic Acids Res (2004) 1.18
YQA14: a novel dopamine D3 receptor antagonist that inhibits cocaine self-administration in rats and mice, but not in D3 receptor-knockout mice. Addict Biol (2011) 1.16
Predictive and prognostic value of KRAS mutations in metastatic colorectal cancer patients treated with cetuximab: a meta-analysis of 22 studies. Eur J Cancer (2010) 1.16
Cyclic RGD conjugated poly(ethylene glycol)-co-poly(lactic acid) micelle enhances paclitaxel anti-glioblastoma effect. J Control Release (2010) 1.15
COLD-PCR enrichment of rare cancer mutations prior to targeted amplicon resequencing. Clin Chem (2011) 1.14
Applying gold nanoparticles as tumor-vascular disrupting agents during brachytherapy: estimation of endothelial dose enhancement. Phys Med Biol (2010) 1.14
Depression and associated factors in internal migrant workers in China. J Affect Disord (2011) 1.13
The membrane-proximal region of vesicular stomatitis virus glycoprotein G ectodomain is critical for fusion and virus infectivity. J Virol (2003) 1.13
Computer-assisted orbital volume measurement in the surgical correction of late enophthalmos caused by blowout fractures. Ophthal Plast Reconstr Surg (2003) 1.13
Cyclin-dependent kinase inhibitors attenuate protein hyperphosphorylation, cytoskeletal lesion formation, and motor defects in Niemann-Pick Type C mice. Am J Pathol (2004) 1.12
Potentially functional variants of PLCE1 identified by GWASs contribute to gastric adenocarcinoma susceptibility in an eastern Chinese population. PLoS One (2012) 1.12
Prediction of microRNAs associated with human diseases based on weighted k most similar neighbors. PLoS One (2013) 1.11
MicroRNA-1285 inhibits the expression of p53 by directly targeting its 3' untranslated region. Biochem Biophys Res Commun (2010) 1.10
Circulating microRNAs: a novel class of potential biomarkers for diagnosing and prognosing central nervous system diseases. Cell Mol Neurobiol (2013) 1.09
Effect of dental restorations and prostheses on radiotherapy dose distribution: a Monte Carlo study. J Appl Clin Med Phys (2009) 1.09
In vitro radiosensitization by gold nanoparticles during continuous low-dose-rate gamma irradiation with I-125 brachytherapy seeds. Nanomedicine (2012) 1.08
BMI1 and Mel-18 oppositely regulate carcinogenesis and progression of gastric cancer. Mol Cancer (2010) 1.08
Multiple aneurysms of distal anterior cerebral artery associated with a cerebral arteriovenous malformation. Neurol India (2010) 1.08
Soluble CD14: genomewide association analysis and relationship to cardiovascular risk and mortality in older adults. Arterioscler Thromb Vasc Biol (2012) 1.08
Thermal stability and inactivation of hepatitis C virus grown in cell culture. Virol J (2010) 1.07
Compact designer TALENs for efficient genome engineering. Nat Commun (2013) 1.06
DNA degradation test predicts success in whole-genome amplification from diverse clinical samples. J Mol Diagn (2007) 1.05
Late reconstruction of the complex orbital fractures with computer-aided design and computer-aided manufacturing technique. J Craniofac Surg (2007) 1.05
Polymorphisms in ERCC1 and XPF genes and risk of gastric cancer in an eastern Chinese population. PLoS One (2012) 1.05
An update on chemotherapy of colorectal liver metastases. World J Gastroenterol (2012) 1.05
Attenuated expression of xeroderma pigmentosum group C is associated with critical events in human bladder cancer carcinogenesis and progression. Cancer Res (2007) 1.05
Primary treatment of acute dacryocystitis by endoscopic dacryocystorhinostomy with silicone intubation guided by a soft probe. Ophthalmology (2009) 1.05
Identification of cardiac troponin I sequence motifs leading to heart failure by induction of myocardial inflammation and fibrosis. Circulation (2008) 1.05
Statins: multiple neuroprotective mechanisms in neurodegenerative diseases. Exp Neurol (2010) 1.04
Characteristics of fecal and mucosa-associated microbiota in Chinese patients with inflammatory bowel disease. Medicine (Baltimore) (2014) 1.03
A pH-responsive cyclodextrin-based hybrid nanosystem as a nonviral vector for gene delivery. Biomaterials (2013) 1.03
Methylation of the ATM promoter in glioma cells alters ionizing radiation sensitivity. Biochem Biophys Res Commun (2006) 1.03
TNF gene polymorphisms and Helicobacter Pylori infection in gastric carcinogenesis in Chinese population. Am J Gastroenterol (2005) 1.03
Present status and perspectives of colorectal cancer in Asia: Colorectal Cancer Working Group report in 30th Asia-Pacific Cancer Conference. Jpn J Clin Oncol (2010) 1.03
Clinical pharmacokinetics, metabolism, and drug-drug interaction of carfilzomib. Drug Metab Dispos (2012) 1.02
Stable siRNA-mediated silencing of ATM alters the transcriptional profile of HeLa cells. Biochem Biophys Res Commun (2004) 1.02
Serotonin transporter gene-linked polymorphic region (5-HTTLPR) influences decision making under ambiguity and risk in a large Chinese sample. Neuropharmacology (2010) 1.01
Full COLD-PCR protocol for noninvasive prenatal diagnosis of genetic diseases. Clin Chem (2010) 1.00
Selective hydrogenation by Pd nanoparticles embedded in polyelectrolyte multilayers. J Am Chem Soc (2004) 1.00
DNA damage enhancement from gold nanoparticles for clinical MV photon beams. Radiat Res (2012) 0.99
Multicenter phase II study of apatinib in non-triple-negative metastatic breast cancer. BMC Cancer (2014) 0.99
Oncogenic role of the chromobox protein CBX7 in gastric cancer. J Exp Clin Cancer Res (2010) 0.99
Unequal sister chromatid and homolog recombination at a tandem duplication of the A1 locus in maize. Genetics (2006) 0.99
A comparison of RNA amplification techniques at sub-nanogram input concentration. BMC Genomics (2009) 0.99
Does simplicity compromise accuracy in ACS risk prediction? A retrospective analysis of the TIMI and GRACE risk scores. PLoS One (2009) 0.99
Icaritin shows potent anti-leukemia activity on chronic myeloid leukemia in vitro and in vivo by regulating MAPK/ERK/JNK and JAK2/STAT3 /AKT signalings. PLoS One (2011) 0.98
Gastric carcinoma in China: Current status and future perspectives (Review). Oncol Lett (2010) 0.98
Simultaneous determination of stilbenes, phenolic acids, flavonoids and anthraquinones in Radix polygoni multiflori by LC-MS/MS. J Pharm Biomed Anal (2011) 0.98
Surgical treatment for patients with Krukenberg tumor of stomach origin: clinical outcome and prognostic factors analysis. PLoS One (2013) 0.98
Influence of extracellular polymeric substances on Pseudomonas aeruginosa transport and deposition profiles in porous media. Environ Sci Technol (2007) 0.97
COLD-PCR: improving the sensitivity of molecular diagnostics assays. Expert Rev Mol Diagn (2011) 0.97
A Phase I study of KH901, a conditionally replicating granulocyte-macrophage colony-stimulating factor: armed oncolytic adenovirus for the treatment of head and neck cancers. Cancer Biol Ther (2009) 0.97
MicroRNA expression profiling in diabetic GK rat model. Acta Biochim Biophys Sin (Shanghai) (2009) 0.97